Rosacea papulopustular disease.
Conditions
Interventions
Intervention 1: First Intervention group:use of permethrin 5% topical cream produced by Gilan daroo company for 12 weeks on cutaneus lesions for 20 papulopustular rosacea patients and photography from
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of typical papulopustular rosacea according two dermatologists and performance biopsy if rosacea is suspected No treatment with topical steroids or other topical treatment during 14 days before starting study No treatment with any systemic drugs by known effect on inflammation responses during 30 days before starting study No treatment with topical retinoids during 30 days ago or systemic retinoids during 180 days before starting study No treatment by physical modality that effect on rosacea lesions during 30 days before starting study Absence of other cutaneous diseases that interfere with assessment lesions related to rosacea Absence of comedon, cyst and scar that benefit to diagnosis of acne vulgaris Absence of pregnancy and breastfeeding
Exclusion criteria
Exclusion criteria: Less than 18 years Male gender
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase or decrease number and severity after use Ivermectin 1% cream or permetrin 5% cream. Timepoint: 0,6 and 12 weeks after starting treatment. Method of measurement: Photography from lesions and remission of lesions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazila Poostiyan
Esfahan University of Medical Sciences
Outcome results
None listed